Shanghai Haohai Biological Technology Statistics

Total Valuation

Shanghai Haohai Biological Technology has a market cap or net worth of HKD 12.86 billion. The enterprise value is 10.77 billion.

Market Cap	12.86B
Enterprise Value	10.77B

Important Dates

The next estimated earnings date is Friday, October 25, 2024.

Earnings Date	Oct 25, 2024
Ex-Dividend Date	Sep 20, 2024

Share Statistics

Shanghai Haohai Biological Technology has 231.72 million shares outstanding. The number of shares has increased by 14.87% in one year.

Shares Outstanding	231.72M
Shares Change (YoY)	+14.87%
Shares Change (QoQ)	-58.66%
Owned by Insiders (%)	63.10%
Owned by Institutions (%)	11.59%
Float	85.50M

Valuation Ratios

The trailing PE ratio is 21.71 and the forward PE ratio is 12.92.

PE Ratio	21.71
Forward PE	12.92
PS Ratio	3.53
PB Ratio	1.20
P/FCF Ratio	22.90
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.46, with an EV/FCF ratio of 33.90.

EV / Earnings	22.47
EV / Sales	3.65
EV / EBITDA	16.46
EV / EBIT	23.79
EV / FCF	33.90

Financial Position

The company has a current ratio of 4.60, with a Debt / Equity ratio of 7.00.

Current Ratio	4.60
Quick Ratio	3.87
Debt / Equity	7.00
Debt / EBITDA	0.70
Debt / FCF	1.43
Interest Coverage	37.80

Financial Efficiency

Return on equity (ROE) is 6.94% and return on invested capital (ROIC) is 4.11%.

Return on Equity (ROE)	6.94%
Return on Assets (ROA)	3.63%
Return on Capital (ROIC)	4.11%
Revenue Per Employee	1.35M
Profits Per Employee	220,013
Employee Count	2,158
Asset Turnover	0.38
Inventory Turnover	1.61

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -8.03% in the last 52 weeks. The beta is 0.74, so Shanghai Haohai Biological Technology's price volatility has been lower than the market average.

Beta (5Y)	0.74
52-Week Price Change	-8.03%
50-Day Moving Average	30.62
200-Day Moving Average	29.01
Relative Strength Index (RSI)	62.50
Average Volume (20 Days)	120,556

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Shanghai Haohai Biological Technology had revenue of HKD 2.95 billion and earned 479.41 million in profits. Earnings per share was 1.45.

Revenue	2.95B
Gross Profit	2.05B
Operating Income	452.67M
Pretax Income	559.76M
Net Income	479.41M
EBITDA	631.69M
EBIT	452.67M
Earnings Per Share (EPS)	1.45

Full Income Statement

Balance Sheet

The company has 2.94 billion in cash and 455.78 million in debt, giving a net cash position of 2.49 billion or 10.73 per share.

Cash & Cash Equivalents	2.94B
Total Debt	455.78M
Net Cash	2.49B
Net Cash Per Share	10.73
Equity (Book Value)	6.51B
Book Value Per Share	26.23
Working Capital	3.13B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 729.55 million and capital expenditures -411.86 million, giving a free cash flow of 317.70 million.

Operating Cash Flow	729.55M
Capital Expenditures	-411.86M
Free Cash Flow	317.70M
FCF Per Share	1.37

Full Cash Flow Statement

Margins

Gross margin is 69.40%, with operating and profit margins of 15.34% and 16.25%.

Gross Margin	69.40%
Operating Margin	15.34%
Pretax Margin	18.97%
Profit Margin	16.25%
EBITDA Margin	21.41%
EBIT Margin	15.34%
FCF Margin	10.77%

Dividends & Yields

This stock pays an annual dividend of 0.88, which amounts to a dividend yield of 2.80%.

Dividend Per Share	0.88
Dividend Yield	2.80%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	47.96%
Buyback Yield	-14.87%
Shareholder Yield	-12.07%
Earnings Yield	4.61%
FCF Yield	4.37%

Dividend Details

Stock Splits

The last stock split was on June 6, 2024. It was a forward split with a ratio of 1.4.

Last Split Date	Jun 6, 2024
Split Type	Forward
Split Ratio	1.4